Quantcast

Latest Biosimilar Stories

2015-02-22 00:20:17

DALLAS, February 22, 2015 /PRNewswire/ -- MarketReportsHub.com adds The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts research

2015-02-20 08:26:19

DUBLIN, Feb .20, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/4rqtv7/global)

2015-02-17 16:26:30

Company currently has two biosimilar applications (filgrastim [Neupogen(®)]) and pegfilgrastim [Neulasta(®)]) under active review by FDA. TORONTO, Feb.

2015-02-16 12:23:38

LONDON, Feb. 16, 2015 /PRNewswire/ -- The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S.

2015-02-13 08:27:51

SAN DIEGO, Feb. 13, 2015 /PRNewswire/ -- Pfenex Inc.

2015-02-12 12:27:45

MUMBAI, February 12, 2015 /PRNewswire/ -- Date Info: 10 Mar 2015 to 11 Mar 2015 Venue Info: The Kensington Close Hotel, Wrights Lane, London, UK

2015-02-11 08:32:46

LONDON, February 11, 2015 /PRNewswire/ -- Report Details Biosimilar therapeutic antibodies - see why originator companies should now fear those competitors,

2015-02-10 23:05:53

BCC Research (http://www.bccresearch.com) reveals in its new report on antibody drugs that increasing competition and new technologies are

2015-02-10 08:34:14

SAN DIEGO and LAKE FOREST, Ill., Feb. 10, 2015 /PRNewswire/ -- Pfenex Inc.


Word of the Day
dipsas
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.